Postintervention Patency Rates and Predictors of Patency after Percutaneous Interventions on Intragraft Stenoses

Andre B Bautista1, Paul V Suhocki1, Waleska M Pabon-Ramos1

  • 1Division of Vascular and Interventional Radiology, Duke University Medical Center, Box 3808, 2311 Erwin Rd., Durham, NC 27710.

Insights

Endovascular intervention for failing arteriovenous (AV) grafts showed moderate primary patency but good secondary patency. Stenting improved lesion patency, while graft thrombosis and concurrent lesions predicted worse outcomes.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Nephrology

Background:

  • Prosthetic arteriovenous (AV) grafts are crucial for hemodialysis access.
  • Intragraft stenosis is a common complication leading to graft failure.
  • Endovascular intervention is a primary treatment modality for failing AV grafts.

Purpose of the Study:

  • To evaluate postintervention patency rates after endovascular treatment of intragraft stenoses in prosthetic AV grafts.
  • To identify predictors of patency following these interventions.

Main Methods:

  • Retrospective review of 183 patients undergoing percutaneous intervention for first-time intragraft stenoses over 7 years.
  • Kaplan-Meier analysis for patency rates and Cox proportional-hazards model for predictors.
  • Definition of intragraft stenosis: 2 cm or more from anastomoses.

Main Results:

  • 229 intragraft stenoses treated in 183 grafts; 62% presented with graft thrombosis.
  • Anatomic success rate of angioplasty was 85%; 15% required stent/stent-graft.
  • 6-month primary, secondary, and lesion-specific patency rates were 40%, 77%, and 75%, respectively.
  • Graft thrombosis and concurrent nonintragraft lesions were negative predictors of primary patency.
  • Stent/stent-graft deployment was a positive predictor of lesion patency.

Conclusions:

  • Endovascular intervention for intragraft stenosis yields moderate primary patency but significant secondary patency.
  • Stent or stent-graft deployment may enhance lesion patency.
  • Graft thrombosis and concurrent lesions negatively impact primary patency outcomes.
Abstract